glp-1-based treatments approved for weight loss 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Patent and Innovation Trends in

BFM, body fat mass

This is why most experts recommend viewing these as long-term therapies rather than short-term interventions

However, many patients prefer injecting after a small meal because it helps them avoid nausea in the minutes following the shot

Pearls and Quotes Clinical Implementation of GLP-1 Receptor Agonists GLP-1 agonists work through a variety of mechanisms to counteract metabolic disease

Preserving that muscle with regular strength work directly protects your venous circulation

Youll also continue to have regular follow-ups with a healthcare team to help you manage their dosage and any side effects they experience